Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 21.13±5.52 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 21.82 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 24.08±9.54 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| 1-(3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-3-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea | 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea | 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea |
| 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA | 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl)urea | 1-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea |
| 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea | 1-[5-tert-butyl-2-(4-methylphenyl)-3-pyrazolyl]-3-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea | 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea |
| 1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea | 1kv2 | 285983-48-4 |
| 3-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-1-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea | 3-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-1-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea | 4CA-0473 |
| A819503 | AB0033708 | AC-24379 |
| AK-51367 | AKOS005256489 | AOB1672 |
| AS-19375 | AX8126847 | B96 |
| BCP01896 | BCP9000416 | BCPP000333 |
| BDBM13533 | BIBR-796 | BIRB 0796 |
| BIRB 796 | BIRB 796 (Doramapimod) | BIRB 796 BS |
| BIRB 796,Doramapimod | BIRB 796BS | BIRB-0796 |
| BIRB-796 | BIRB-796 BS | BIRB-796, 3 |
| BIRB-796-(Doramapimod) | BIRB796 | BRD-K74065929-001-01-5 |
| C31H37N5O3 | CAS-285983-48-4 | CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C |
| CHEBI:40953 | CHEMBL103667 | CS-0219 |
| CTK8F0049 | D03736 | DB03044 |
| DSSTox_CID_28883 | DSSTox_GSID_48957 | DSSTox_RID_83151 |
| DTXSID2048957 | Doramapimod | Doramapimod (BIRB 796) |
| Doramapimod (BIRB-796) | Doramapimod (USAN/INN) | Doramapimod [USAN:INN] |
| Doramapimod, BIRB-796 | FT-0667779 | GTPL5668 |
| HMS3655C07 | HMS3747G11 | HO1A8B3YVV |
| HY-10320 | KIN0000097 | KS-00000XIY |
| KS-00001PQT | Kinome_2137 | MLS006010153 |
| MVCOAUNKQVWQHZ-UHFFFAOYSA-N | N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]- N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-urea | N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea |
| N-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea; | NCGC00241104-01 | NCGC00241104-02 |
| NCGC00241104-07 | PubChem18416 | Q-101419 |
| Q27077098 | RT-012412 | S-7738 |
| SB16634 | SC-19868 | SCHEMBL129721 |
| SMR004458704 | SR-00000002531 | SR-00000002531-1 |
| ST2406821 | SW219700-1 | Tox21_113386 |
| Tox21_113386_1 | UNII-HO1A8B3YVV | US8933228, BIRB 796 |
| Urea, N-(3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-N'-(4-(2-(4-morpholinyl)ethoxy)-1-naphthalenyl)- | Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]- | X7401 |
| ZINC000024044436 | ZINC24044436 | cid_156422 |
| diaryl urea compound 10 | s1574 |